The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Company profile

Akari Therapeutics Plc insider acquisitions

Company CIK 0001541157 · Reported insider acquisitions and filing context.

Company filings at SEC ↗
AKTX · Nasdaq

These are company listings. A transaction is linked to a particular security only when the filing provides enough information.

Company activity summary

By transaction date, as of October 23, 2026.

7 days30 days90 daysOverlapping periods · securities and currencies kept separate
30-day company acquisitions grouped by security, category, original code, and currency.
Type / codeReported securityTransactionsKnown purchase valueMissing amounts
Stock awardCode AAmerican Depositary Shares representing Ordinary SharesNon-derivative · Currency not specified6Not applicable0
Stock awardCode AStock Option (Right to Buy)Derivative · Currency not specified1Not applicable0
Exercise / conversionCode MAmerican Depositary Shares representing Ordinary SharesNon-derivative · Currency not specified6Not applicable0

Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Gaslightwala AbizerGaslightwala AbizerBazemore Robert BBazemore Robert BFarag Kameel D.Farag Kameel D.Gaslightwala Abizer · December 16, 2025 · Purchase · Warrants to purchase American Depositary Shares ("ADRs")Bazemore Robert B · December 16, 2025 · Purchase · Pre-Funded Warrants to purchase ADRsBazemore Robert B · December 16, 2025 · Purchase · Warrants to purchase ADRsBazemore Robert B · December 16, 2025 · Purchase · Pre-Funded Warrants to purchase ADRsBazemore Robert B · December 16, 2025 · Purchase · Warrants to purchase American Depositary Shares ("ADRs")Farag Kameel D. · November 1, 2025 · Stock award · American Depositary Shares representing Ordinary SharesFarag Kameel D. · November 1, 2025 · Stock award · American Depositary Shares representing Ordinary SharesFarag Kameel D. · October 22, 2025 · Stock award · American Depositary Shares representing Ordinary SharesOct 22, 2025Dec 16, 2025
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

8 dated transactions · 3 of 3 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Dec 16, 2025Akari Therapeutics PlcWarrants to purchase American Depositary Shares ("ADRs")Gaslightwala AbizerPurchase
Dec 16, 2025Akari Therapeutics PlcPre-Funded Warrants to purchase ADRsBazemore Robert BPurchase
Dec 16, 2025Akari Therapeutics PlcWarrants to purchase ADRsBazemore Robert BPurchase
Dec 16, 2025Akari Therapeutics PlcPre-Funded Warrants to purchase ADRsBazemore Robert BPurchase
Dec 16, 2025Akari Therapeutics PlcWarrants to purchase American Depositary Shares ("ADRs")Bazemore Robert BPurchase
Nov 1, 2025Akari Therapeutics PlcAmerican Depositary Shares representing Ordinary SharesFarag Kameel D.Stock award
Nov 1, 2025Akari Therapeutics PlcAmerican Depositary Shares representing Ordinary SharesFarag Kameel D.Stock award
Oct 22, 2025Akari Therapeutics PlcAmerican Depositary Shares representing Ordinary SharesFarag Kameel D.Stock award

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Share price & reported acquisitions

Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.

Price history is not available

Market-price history is not connected yet.

AKTX · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.

Reported acquisitions

Filing-date filters apply to the list and timeline. The summary above uses transaction dates.

Reset
Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedReporting ownersType / securityQuantityPrice / reference valueDetails
Trade:
Gaslightwala AbizerCEO · Director
PurchaseWarrants to purchase American Depositary Shares ("ADRs")Derivative security · Code P309,328Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: PurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P30,9320.4041 *Value: 12,499.6212Currency not specifiedView ↗
Trade: PurchaseWarrants to purchase ADRsDerivative security · Code P30,932Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: PurchasePre-Funded Warrants to purchase ADRsDerivative security · Code P123,7310.4041 *Value: 49,999.6971Currency not specifiedView ↗
Trade: PurchaseWarrants to purchase American Depositary Shares ("ADRs")Derivative security · Code P123,731Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade:
Farag Kameel D.Interim CFO
Stock awardAmerican Depositary Shares representing Ordinary SharesNon-derivative security · Code A26,6190.75Value: 19,964.25Currency not specifiedView ↗
Trade:
Farag Kameel D.Interim CFO
Stock awardAmerican Depositary Shares representing Ordinary SharesNon-derivative security · Code A32,0000.75Value: 24,000Currency not specifiedView ↗
Trade:
Farag Kameel D.Interim CFO
Stock awardAmerican Depositary Shares representing Ordinary SharesNon-derivative security · Code A6,2770.74Value: 4,644.98Currency not specifiedView ↗

Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →